Upstream Bio Ownership | Who Owns Upstream Bio?


OverviewRevenueFinancialsChart

Upstream Bio Ownership Summary


Upstream Bio is owned by 84.50% institutional investors, 19.81% insiders.

UPB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockUpstream Bio84.50%19.81%-4.31%
SectorHealthcare Stocks 278.45%10.60%-189.04%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202577-45,306,251-84-77---

Insider Transactions Trends


DateBuySell
2025 Q2--

UPB Ownership FAQ


Who Owns Upstream Bio?

Upstream Bio shareholders are primarily institutional investors at 84.50%, followed by 19.81% insiders and -4.31% retail investors. The average institutional ownership in Upstream Bio's industry, Biotech Stocks , is 63.84%, which Upstream Bio exceeds.

Does Blackrock own Upstream Bio?

BlackRock is not among the top 10 institutional shareholders of Upstream Bio.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools